この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
規制と法律 · 1999/10/71 分で読めます
Revisions to the Commerce Control List (ECCNs 1C351, 1C991, and 2B351): Medical Products Containing Biological Toxins; and Toxic Gas Monitoring Systems and Dedicated Detectors
ローカル自動翻訳 · 情報源の原言語
概要
This final rule amends the Commerce Control List (CCL) of the Export Administration Regulations to implement an October 1998 Australia Group agreement to amend controls on toxic gas monitoring systems and dedicated detectors. This final rule also amends the CCL to authorize, without a license, exports of medical products containing controlled biological toxins (except saxitoxin and ricin) that are developed, packaged and sold for medical treatment. This rule will result in a decreased licensing burden on U.S. industry.
情報源の原言語: Federal Register — All Documents原文の発表を開く →